| Literature DB >> 22453170 |
Danielle Gonsalves1, Katarina Jovanovic, Bianca Da Costa Dias, Stefan F T Weiss.
Abstract
We report here on the proceedings of the Global Alzheimer Summit that took place September 22-23, 2011 in Madrid, Spain. As Alzheimer disease (AD) is the leading cause of neurodegeneration in elderly individuals and as yet has no effective therapeutic option, it continues to stimulate global research interests. At the conference, leaders in the field of AD research provided insights into current developments in various areas of research, namely molecular mechanisms, genetics, novel aspects of AD research and translational research. Emphasis was also placed on the importance of biomarkers in the diagnosis of AD and development of current therapeutic strategies.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22453170 PMCID: PMC3338957 DOI: 10.4161/pri.6.1.18854
Source DB: PubMed Journal: Prion ISSN: 1933-6896 Impact factor: 3.931